TYRA insider transactions
Tyra Biosciences Inc. (TYRA) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
TYRA insiders
Everyone who has filed a Form 3, 4, 5 or 144 at Tyra Biosciences Inc., latest first. Follow anyone to get their next filing.
- Todd HarrisPresident and CEO, Director-$8.12M
- Yuliya RuebVice President, Finance (PAO), since April 2026
- Alan FuhrmanChief Financial Officer, since January 2023+$152K
- Ra Capital Management, L.P.Director, 10% owner+$35.2M
- Rehan VerjeeDirector+$20K
- Nextech Vi Oncology ScspInsider
- Susan MoranDirector, since May 2024
- Jake SimsonDirector
- Adele M. GulfoDirector, since January 2025
- Stephen Michael RothenbergDirector, since May 2024
- Robert J MoreDirector-$5.25M
- Douglas J WarnerChief Medical Officer, since September 2024
- Bhavesh AsharChief Operating Officer
- Habib J DableDirector, since April 2026
- Gilla KaplanDirector-$1.16M
- Daniel BensenChief Discovery Officer-$9.54M
- Alta Partners NextGen Fund II, L.P.Insider
- Nina S KjellsonDirector-$4.41M
- Canaan XI L.P.Director
- Boxer Capital Management, LLCInsider, since October 2024
- Siddarth SubramonyDirector, 10% owner
- Hiroomi TadaChief Medical Officer
- Boxer Capital, LLCInsider+$1.64M
- Isan ChenDirector
- Piyush R. PatelOfficer
- MVA Investors, LLC10% owner-$3.5M
- Esther van den BoomOfficer
- Robert L. HudkinsOfficer
- Ronald V. SwansonOfficer
- Ali D. FawazOfficer, since May 2022
- John Stephen HealyOfficer, since March 2022
Recent Form 3, 4, and 5 filings for TYRA
- President and CEO Harris Todd was granted 864 shares, increasing direct ownership by 0.06% to 1,438,495 units (SEC Form 4)4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- Vice President, Finance (PAO) Rueb Yuliya was granted 2,925 shares, increasing direct ownership by 35% to 11,258 units (SEC Form 4)4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- Chief Financial Officer Fuhrman Alan was granted 951 shares, increasing direct ownership by 3% to 37,115 units (SEC Form 4)4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- SEC Form 4 filed by Director Ra Capital Management, L.P.4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- Director Verjee Rehan bought $20,000 worth of shares (972 units at $20.58) (SEC Form 4)4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- SEC Form 4 filed by Director Ra Capital Management, L.P.4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- SEC Form 4 filed by Director Simson Jake4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- SEC Form 4 filed by Director Moran Susan4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- SEC Form 4 filed by Director Verjee Rehan4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- SEC Form 4 filed by Director Gulfo Adele M.4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- SEC Form 4 filed by Director Rothenberg Stephen Michael4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- SEC Form 4 filed by Director More Robert J4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- Chief Medical Officer Warner Douglas J was granted 25,000 shares (SEC Form 4)4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- President and CEO Harris Todd was granted 79,000 shares, increasing direct ownership by 6% to 1,437,631 units (SEC Form 4)4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- Chief Financial Officer Fuhrman Alan was granted 20,000 shares, increasing direct ownership by 124% to 36,164 units (SEC Form 4)4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- Vice President, Finance (PAO) Rueb Yuliya was granted 8,333 shares, increasing direct ownership by 24% to 43,354 units (SEC Form 4)4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- Chief Operating Officer Ashar Bhavesh was granted 15,013 shares (SEC Form 4)4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- SEC Form 4 filed by Dable Habib J4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- SEC Form 3 filed by new insider Dable Habib J3 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- SEC Form 3 filed by new insider Rueb Yuliya3 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- SEC Form 4 filed by Kaplan Gilla4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- Chief Financial Officer Fuhrman Alan was granted 1,376 shares, increasing direct ownership by 9% to 16,164 units (SEC Form 4)4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- President and CEO Harris Todd was granted 1,463 shares, increasing direct ownership by 0.11% to 1,358,631 units (SEC Form 4)4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- Chief Discovery Officer Bensen Daniel sold $262,965 worth of shares (8,000 units at $32.87), decreasing direct ownership by 5% to 146,981 units (SEC Form 4)4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- Chief Discovery Officer Bensen Daniel sold $228,186 worth of shares (8,000 units at $28.52), decreasing direct ownership by 5% to 154,981 units (SEC Form 4)4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- Director More Robert J sold $250,000 worth of shares (10,000 units at $25.00) (SEC Form 4)4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- Chief Discovery Officer Bensen Daniel sold $181,159 worth of shares (8,000 units at $22.64), decreasing direct ownership by 5% to 162,981 units (SEC Form 4)4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- SEC Form 4 filed by Chief Operating Officer Ashar Bhavesh4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- SEC Form 3 filed by Tyra Biosciences Inc.3 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- Director More Robert J sold $5,000,026 worth of shares (246,871 units at $20.25) (SEC Form 4)4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- Chief Operating Officer Bensen Daniel sold $2,030,923 worth of shares (125,589 units at $16.17), decreasing direct ownership by 42% to 170,981 units (SEC Form 4)4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- Chief Operating Officer Bensen Daniel sold $2,108,067 worth of shares (131,411 units at $16.04), decreasing direct ownership by 31% to 296,570 units (SEC Form 4)4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- Chief Financial Officer Fuhrman Alan was granted 701 shares, increasing direct ownership by 5% to 14,788 units (SEC Form 4)4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Fuhrman Alan4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- SEC Form 4 filed by Chief Operating Officer Bensen Daniel4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Warner Douglas J4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- SEC Form 4 filed by President and CEO Harris Todd4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- Director Kaplan Gilla sold $93,700 worth of shares (9,578 units at $9.78), decreasing direct ownership by 25% to 28,231 units (SEC Form 4)4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- Director Ra Capital Management, L.P. bought $1,664,700 worth of shares (163,287 units at $10.19) (SEC Form 4)4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- Director Kaplan Gilla sold $534,563 worth of shares (51,814 units at $10.32), decreasing direct ownership by 58% to 37,809 units (SEC Form 4)4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- Director Ra Capital Management, L.P. bought $1,904,002 worth of shares (186,850 units at $10.19) (SEC Form 4)4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- Director Ra Capital Management, L.P. bought $11,751,304 worth of shares (1,211,198 units at $9.70) (SEC Form 4)4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- SEC Form 4 filed by Director Ra Capital Management, L.P.4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- SEC Form 4 filed by Director Moran Susan4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- SEC Form 4 filed by Director More Robert J4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- SEC Form 4 filed by Director Rothenberg Stephen Michael4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- SEC Form 4 filed by Director Simson Jake4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- SEC Form 4 filed by Director Kaplan Gilla4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- SEC Form 4 filed by Director Verjee Rehan4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- President and CEO Harris Todd was granted 1,241 shares, increasing direct ownership by 0.09% to 1,357,168 units (SEC Form 4)4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- Chief Financial Officer Fuhrman Alan was granted 1,238 shares, increasing direct ownership by 10% to 14,087 units (SEC Form 4)4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- Director Kjellson Nina S sold $74,324 worth of shares (5,401 units at $13.76) (SEC Form 4)4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- SEC Form 4 filed by Director Gulfo Adele M.4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- New insider Gulfo Adele M. claimed ownership of 4,000 shares (SEC Form 3)3 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- Director Kjellson Nina S sold $78,466 worth of shares (4,825 units at $16.26) (SEC Form 4)4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- Director Kjellson Nina S sold $409,645 worth of shares (25,041 units at $16.36) (SEC Form 4)4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- Director Kjellson Nina S sold $88,773 worth of shares (5,272 units at $16.84) (SEC Form 4)4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- Director Ra Capital Management, L.P. bought $19,836,066 worth of shares (1,220,681 units at $16.25) (SEC Form 4)4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- Director Kjellson Nina S sold $1,284,133 worth of shares (74,582 units at $17.22) (SEC Form 4)4 - Tyra Biosciences, Inc. (0001863127) (Issuer)
- Director Kjellson Nina S sold $194,248 worth of shares (11,569 units at $16.79) (SEC Form 4)4 - Tyra Biosciences, Inc. (0001863127) (Issuer)